Oral single-active-ingredient pantothenic acid supplementation,
does it really help with Reduction in LDL-C concentration in adults with elevated LDL-C?
research showsThe currently verified material does not establish that oral pantothenic acid alone lowers LDL-C more than placebo or usual care on the same background treatment. Related human lipid trials exist, but their intervention is pantethine or a multicomponent product, so their results were not attributed to pantothenic acid alone. ? is a current judgment of no directly eligible result verified within the recorded search, not no effect or worldwide absence of studies. [S101][S105]
ads claimNutritional functions of pantothenic acid, lipid metabolism in animals, B-complex absorption and LDL lowering by the different molecule pantethine do not establish this monotherapy. LDL-C is a surrogate; it does not establish fewer cardiovascular events or replacement of lipid-lowering medicines. [S103][S105][S101]
Four separate assessment dimensions
| Effect direction and size | No directly eligible LDL-C comparison for pantothenic-acid monotherapy verified |
|---|---|
| Evidence certainty | ? is scoped uncertainty, not no effect |
| Applicability | Adults with elevated LDL-C; oral pantothenic acid as the sole active ingredient; placebo or usual care on matched background treatment |
| Safety | Caution |
B / S / null / null / null / null / null; score and strength count null
Useful facts when choosing a product
- The eligible single product's manufacturing origin, brand, exact salt, purity, batch, tablet/capsule, release type, dose, frequency and duration are unverified.
- No verified inputs were obtained to convert calcium-pantothenate mass into pantothenic-acid mass, and clinical equivalence of the forms was not asserted. [S06]
- The mechanistic pantothenic-acid paper used adult male mice and primary adipocytes, not a controlled human LDL-C trial. [S103]
- The inspected NCT03444155 protocol compares B-complex formulations. Registrations and reports were not counted as eligible single-ingredient trials. [S105][S106]
Chamgap Semantic Classification Code
Permanent code issued
S.pantothenic-acid.oral.ldl-cholesterol.reduce.placeboSubstances and nutrients > Pantothenic acid (vitamin B5), sole active ingredient > Oral > LDL cholesterol > Reduction claim > Placebo
Bound to the LDL-C claim for oral pantothenic acid monotherapy. Pantethine and B-complex products are distinct interventions; a directly eligible pantothenic-acid result remains unverified. The code identifies the intervention and claim; it never contains the evidence grade, score, or safety result.
Exact Claim Classification
These independent facets prevent evidence from different forms, routes, populations, effects, and comparators from being mixed.
| Intervention class | S · Supplement or nutraceutical |
|---|---|
| Canonical ingredient or intervention | Pantothenic acid (vitamin B5), sole active ingredient; calcium salt assessed separately |
| Source or part used | Not verified — eligible monotherapy manufacturing origin, purity and batch unverified |
| Formulation or processing | Single-active oral preparation; exact salt, tablet/capsule and release type unverified |
| Route | Oral |
| Dose | Not verified — eligible pantothenic-acid monotherapy dose and frequency unverified |
| Duration | Not verified — eligible treatment duration and timing unverified |
| Population | Adults with elevated LDL-C; actual diagnostic threshold, baseline, medicines and deficiency unverified |
| Effect or condition | Reduction in LDL-C concentration |
| Primary endpoint | Between-group LDL-C concentration change (mg/dL or mmol/L); endpoint difference separate, actual eligible results unverified |
| Comparator | Placebo/usual care on matched background treatment; actual composition and common treatments unverified |
| Duplicate-detection key | pantothenic-acid|oral-single-active-exact-salt-not-verified|dose-not-verified|adults-with-elevated-ldl-c|ldl-c-between-group-change|duration-not-verified|placebo-or-usual-care-on-matched-background-treatment |
What the research actually shows
For this fixed question, LDL-C baseline, change and endpoint values, arm-specific analysis denominators, between-group change difference, CI, P value and assessment time remain unverified. Information distinguishing directly measured LDL from formula-calculated LDL is also unavailable. No conversion between mmol/L and mg/dL or reconstruction from graphs was performed. Adjacent pantethine results were not inserted as pantothenic-acid data. [S101]
Why this is classified as ?
Applying the supplied original rubric and calculator's direct-human-evidence gate to this single claim yields ? with null score. The 7 axes are B / S / null / null / null / null / null. LDL-C is laboratory surrogate S. The last five axes and strength count are unscored, not 0. Neither pantethine's C with 52 points nor the C in the skin composite record was inherited.
Counterpoint. Without a verified direct monotherapy trial, no repeated refutation or 0 effect is asserted. Nonhuman research, pantethine, B-complex products, enriched margarine and multicomponent lipid-product leads were separated for their respective reasons. Inaccessible full texts or registrations were not counted as negative trials. [S103][S105][S107][S108]
Rejudgment record. No directly eligible controlled single-ingredient LDL-C result verified — Original rubric stage 0, LDL-C endpoint S; subsequent axes not applied
| Endpoint | S | Surrogate marker - laboratory or imaging measures |
Stored derived and displayed grades match; this is not a current recalculation or validity check (?).
Review performed and remaining limitations
Directly eligible pantothenic-acid monotherapy results, exact salt, formulation, dose, duration, population threshold and between-group LDL-C values remain unverified
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Evans 2014 pantethine trial — a different molecule from pantothenic acid | Triple-blinded placebo- and diet-controlled pantethine trial | 32 randomized and 24 completed; excluded from direct pantothenic-acid evidence | Funded by Daiichi Fine Chemical Co Ltd; information pertains to the pantethine trial | Not eligible for this single-ingredient LDL-C question | LDL results exist but are excluded from direct efficacy because the molecule differs | Excluded from direct grading |
| Zhao nonhuman mechanistic study of pantothenic-acid metabolism | Mice and primary adipocytes; possibly related preprint | Adult male mice and primary adipocytes; no human analysis denominator applies | Not verified from the accessed abstract | Not eligible for this single-ingredient LDL-C question | Nonhuman mechanistic findings not transferred to human monotherapy LDL efficacy | Excluded from direct grading |
| NCT03444155 protocol comparing natural and synthetic B-complex products | B-complex study protocol | Actual randomized count and results unverified; no pantothenic-acid monotherapy denominator | Not extracted for this excluded protocol | Not eligible for this single-ingredient LDL-C question | Multicomponent intervention/comparator; no direct single-ingredient LDL result verified | Excluded from direct grading |
Receipt — 15 References
Evidence access cutoff: 2026-09-15. Each citation states its actual access level (full-text transcription, abstract, index, or other) and remaining limitations. Bibliographic checking does not certify the study results or treatment efficacy.
Technical integration by: Codex · Evidence date: 2026-09-15 · Corrections: none
Cite this verdict
[Chamgap] Oral pantothenic acid monotherapy × elevated LDL-C concentration — Evidence Grade ?. 15 cited sources checked. Source: https://chamgap.com/en/verdicts/heart/oral-pantothenic-acid-monotherapy-elevated-ldl-cholesterol/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.